Harm reduction
66 articles
Enhancing Hepatitis B and C Prevention Among People Who Use Drugs in Iran
Enhancing hepatitis B and C prevention among people who use drugs: Evaluating an educational intervention at a drop-in center in southwest Iran based on Protection Motivation Theory More
Facilitated Telemedicine Boosts Long-Term Recovery for Patients with HCV and OUD, with Andrew Talal, MD
Integrating facilitated telemedicine into opioid treatment programs led to sustained virological response, improved patient satisfaction, and long-term health gains 5 years post-cure. More
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
Treatment Action Group releases a trials tracker providing a compilation of ongoing and recently completed clinical trials on long-acting therapies for HCV, opioid use and overdose prevention therapy, and malaria in the R&D pipeline. More
Global State of Harm Reduction: 2025 Update to Key Data
The 2025 update summarises key developments in harm reduction services, funding and drug policy since the launch of the 9th edition of the report in November 2024. More
WHO’s New Guidance on Maintaining Opioid Agonist Maintenance Treatment as an Essential Health Service
WHO calls on countries, service planners, providers, policy-makers, and all stakeholders involved in treatment and overdose prevention programmes to ensure live-saving interventions are maintained. More
